Breaking research from science, medicine and technology.

An international research team led by Mount Sinai Heart at Icahn School of Medicine at Mount Sinai, is testing its novel sugar-based tracer contrast agent to be used with positron emission tomography imaging to help in the hunt for dangerous inflammation and high-risk vulnerable atherosclerotic …

1 4,996 4,997 4,998 4,999 5,000 5,561